# Combination Chemotherapy for the Treatment of Indian Kala-Azar

> **NCT00370825** · PHASE2 · COMPLETED · sponsor: **Banaras Hindu University** · enrollment: 200 (—)

## Conditions studied

- Visceral Leishmaniasis

## Interventions

- **DRUG:** Combination therapy with AmBisome and miltefosine

## Key facts

- **NCT ID:** NCT00370825
- **Lead sponsor:** Banaras Hindu University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 200 (—)
- **Last updated:** 2008-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00370825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00370825, "Combination Chemotherapy for the Treatment of Indian Kala-Azar". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00370825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*